Albania vs Latvia: Cause of death, by non-communicable diseases, ages 5-14
Albania
42.4%
in 2021
Latvia
42.3%
in 2021
Albania rank
73rd
Latvia rank
74th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Albania
- Latvia
How they compare
Albania currently reports 42.4% against 42.3% in Latvia, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Latvia ahead.
Albania ranks 73rd and Latvia ranks 74th of 185 countries.
Across the 3 decades both report, Albania averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Albania | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.0% | 38.6% | 6.7% | Latvia |
| 2010s | 41.8% | 48.8% | 7.0% | Latvia |
| 2020s | 44.0% | 43.2% | 0.8% | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Albania or Latvia?
- Albania, at 42.4% against 42.3% in Latvia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Albania and Latvia?
- 0.1%, with Albania ahead.
- How many years of comparable data are there for Albania and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Albania and Latvia rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Albania ranks 73rd and Latvia ranks 74th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.